Genetic Basis of Disease Susceptibility

The genetic basis of disease susceptibility concerns how inherited variation makes individuals more or less likely to develop common diseases that do not follow simple Mendelian patterns. Most common conditions — such as coronary disease, type 2 diabetes, and many cancers and autoimmune disorders — are multifactorial, arising from the combined small effects of many genetic variants together with environmental and lifestyle exposures. This contrasts with single-gene disorders, where one mutation largely determines disease.

Definition

Genetic disease susceptibility is the inherited component of risk for multifactorial diseases, in which many genetic variants of individually small effect combine with environmental exposures to influence whether and when disease develops, rather than a single gene determining the outcome.

Scope

This topic covers the multifactorial (polygenic) architecture of common disease, the role of common and rare variants, genome-wide association studies as the principal discovery tool, the concepts of heritability and missing heritability, and polygenic risk scores as a way to summarize aggregate genetic susceptibility. It is a methodological and conceptual reference, not a basis for predictive genetic testing or individual risk counselling.

Core questions

• Why do common diseases show a multifactorial, polygenic architecture rather than Mendelian inheritance?
• How do genome-wide association studies identify variants associated with disease, and what do association signals mean mechanistically?
• What is 'missing heritability', and what explanations have been proposed for it?
• How do polygenic risk scores aggregate many small effects, and what are their limits?

Key concepts

• Multifactorial (polygenic) inheritance
• Common variant, common disease hypothesis
• Genome-wide association study (GWAS)
• Heritability and missing heritability
• Polygenic risk score
• Gene-environment interaction
• Linkage disequilibrium
• Effect size and allele frequency

Mechanisms

Susceptibility to common disease reflects the joint action of many genetic variants, most of them common in the population and each shifting risk only slightly, together with environmental and behavioural factors. Genome-wide association studies test millions of variants across many individuals to find those statistically associated with disease, exploiting linkage disequilibrium so that genotyped markers tag nearby causal variants. The summed effect of associated variants can be expressed as a polygenic risk score. A persistent observation is that identified variants explain only part of the heritability estimated from family studies — the 'missing heritability' — prompting work on rare variants, structural variation, gene-environment interaction, and broader 'omnigenic' models in which essentially all expressed genes contribute through regulatory networks.

Clinical relevance

Understanding susceptibility architecture clarifies why most common diseases cluster in families without simple inheritance and informs how genetic-association evidence is interpreted in pathology and epidemiology. This entry is conceptual and descriptive; polygenic scores and association findings discussed here are not presented for individual prediction, screening, or clinical decision-making.

Epidemiology

Genome-wide association studies have identified large numbers of risk loci for most common diseases, yet individually these confer small risk changes. Heritability estimates from twin and family studies are typically substantial for common diseases, and the gap between that heritability and the variance explained by discovered variants remains an active area of study.

History

After early candidate-gene and linkage approaches had limited success for common disease, the cataloguing of human variation (the HapMap and SNP maps) enabled genome-wide association studies from the mid-2000s, which rapidly identified thousands of loci. The recognition that these explained only part of family-based heritability framed the 'missing heritability' debate, and later polygenic and omnigenic models reconceived common-disease architecture as highly distributed across the genome.

Debates

What explains the 'missing heritability' of common diseases?

GWAS-identified common variants account for only part of the heritability estimated from family studies; proposed explanations include many undetected small-effect variants, rare variants of larger effect, structural variation, gene-environment interaction, and overestimated heritability, with no single resolution.

Are common diseases polygenic or effectively 'omnigenic'?

Evidence that associated variants are spread across most of the genome led to the proposal that nearly all genes expressed in a relevant cell type contribute to a trait through regulatory networks, extending the polygenic model and reframing how mechanism is inferred from association.

Key figures

• Teri Manolio
• Peter Visscher
• Jonathan Pritchard

Seminal works

• manolio-2009-sus
• visscher-2017
• boyle-2017

Frequently asked questions

How is disease susceptibility different from a genetic disease?

A genetic disease such as a single-gene disorder is largely caused by a specific mutation, whereas disease susceptibility refers to inherited variation that only raises or lowers the probability of developing a common, multifactorial disease, with environment and chance also playing major roles.

What does a genome-wide association study actually find?

It finds genetic variants that occur more often in people with a disease than in those without it across large populations, flagging regions of the genome statistically linked to risk; such associations indicate involvement but do not by themselves prove that a particular variant causes the disease.